About Our Approach to Rare Skin Lymphomas:
With rare lymphomas, the diagnosis is the treatment plan—two lymphomas that look identical on the skin can require entirely different approaches and carry entirely different outlooks.
At Charleston Dermatology, our team evaluates unexplained persistent nodules, plaques, and treatment-resistant rashes with skin biopsies and advanced pathology, including the immunostains and molecular studies needed to classify uncommon lymphoma subtypes accurately.
Treatment is built around your specific diagnosis and may include localized radiation, surgical removal of solitary lesions, skin-directed therapies, or systemic treatment coordinated closely with hematology-oncology. Whatever the subtype, you’ll leave with a clear explanation of what it is and what happens next. Schedule a visit for any skin finding that hasn’t been explained.
Frequently Asked Questions
What other lymphomas can affect the skin
Rarer types include CD30-positive lymphoproliferative disorders (such as lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma), subcutaneous panniculitis-like T-cell lymphoma, and skin involvement from systemic lymphomas. Some of these behave indolently for years; others need prompt systemic treatment — subtype is everything.
How are rare skin lymphomas diagnosed?
Diagnosis starts with a skin biopsy, but rare lymphomas often require more: immunohistochemical stains, molecular clonality studies, blood work, and sometimes imaging to determine whether the disease is confined to the skin. It’s common to need more than one biopsy over time before the picture is definitive.
Who treats rare skin lymphomas?
Usually a team. Dermatology typically leads diagnosis and skin-directed treatment, while hematology-oncology manages any systemic therapy, and radiation oncology delivers localized radiation when indicated. We coordinate that team and remain your home base for skin monitoring throughout.